Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), developed to stimulate the pituitary gland’s release of growth hormone (GH) in a manner that mirrors the body’s natural secretion patterns. Clinically approved for reducing visceral adipose tissue (VAT) in HIV-infected patients with lipodystrophy, Tesamorelin has demonstrated significant reductions in VAT and improvements in metabolic parameters. Its targeted mechanism offers a valuable approach to managing abnormal fat distribution without significantly affecting subcutaneous fat .
| Weight | 10mg |
|---|
42 in stock
All products offered on this website are strictly intended for research and development purposes only. They are not for human consumption in any form.
The statements presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
Superhuman Peptides operates solely as a chemical supplier. It is not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Superhuman Peptides is also not an outsourcing facility as defined under Section 503B of the same Act.
This website contains information about supplementary products. By entering, you confirm that you are of legal age (18 years or older) to access this information. If you are not of legal age, please leave this site immediately.
